SYHA1813
SYHA1813 is a dual inhibitor of CSF1R and VEGFR. SYHA1813 has potent antitumor activity against GBM[1].
Product Specifications
CAS Number
1807466-30-3
UNSPSC
12352005
Target
C-Fms; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/syha1813.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=NNC2=C1C(C3=CC=C4C(C=CC=C4C(NC5=CC=C(F)C(C)=C5)=O)=C3)=CC=C2
Molecular Formula
C25H19FN4O
Molecular Weight
410.44
References & Citations
[1]Yingqiang Liu, et al. Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma. Acta Pharm Sin B. 2023, 13,12.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-T184935-5ML 5 mL
Tri(Propylene Glycol Butyl Ether (Mixture of isomers)
Sign In for Pricing
View Details 
BNC401657-500 1x 500 µL
CD1a / HTA1 (Mature Langerhans Cells Marker), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
